+1 704-993-8389

Advocacy & Awareness for Immune Disorders Association (AAIDA)

Primary Immunodeficiency (PI)

2023 Medicare Part D Enrollment Guide, October 2022
Immunodeficiency Disorders
AAIDA IVIG/SCIG Patient Quick Reference Guide
Treatment of Children with Primary Immunodeficiencies with a Subcutaneous Immunoglobulin 16.5% (Cutaquig® [Octanorm]), May 2021
Addressing the Challenges to Immune Globulin Access, April 2021
Diagnostic and Predictive Contribution of Autoantibodies Screening in a Large Series of Patients With Primary Immunodeficiencies, April 1st, 2021
Primary Immunodeficiency Diseases Treated with Immunoglobulin and Associated Comorbidities, January 2021
Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases, June 10th, 2020
A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy, May 2020
Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG, November 2019
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States, October 2019
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials, November 2018
Primary Immune Deficiency Diseases as Unrecognized Causes of Chronic Respiratory Disease, November 2017
Immunodeficiency, March 2017
Immune-Globulin, January 2017
Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry, January 2017
Ins and Outs of Antibodies, May 2016
X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene, April 3rd, 2016
What Causes CVID? Doctors May Have Discovered the Answer, April 27th, 2016